🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immunization; Infection

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children NCT05758532Phase 41 site📍 Geneva Laure Pittet, MD-PhD · Tests: Measles-Mumps-Rubella vaccine (MMR) Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine Impact of Bacterial Expression and Immune Response in the Severity of Pertussis NCT05897879NA14 sites📍 Bordeaux📍 Colombes📍 Créteil Institut Pasteur · Tests: Nasopharyngeal swab, Blood samples A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. NCT07555392Phase 2, Phase 310 sites📍 Guwahati📍 Patna📍 Raipur Bharat Biotech International Limited · Tests: BBV87 Chikungunya vaccine, Placebo Immunosuppression and COVID-19 Boosters NCT05415267Phase 35 sites📍 Blacktown📍 Camperdown📍 Concord Kirby Institute · Tests: diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months NCT07036159Phase 22 sites📍 Kigali📍 Kigali GlaxoSmithKline · Tests: RTS,S/AS01E vaccine COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research NCT06168032NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: Any Chinese government-recommended COVID-19 booster vaccine Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites📍 Lund📍 Stockholm📍 Uppsala Vastra Gotaland Region · Tests: Early start post-transplant vaccination with Gardasil 9®, Late post-transplant vaccination with Gardasil 9® Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination NCT05422508Phase 21 site📍 Ansan Green Cross Corporation · Tests: MG1111 (BARICELA), VARIVAX, Suduvax Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years NCT06891417Phase 1, Phase 27 sites📍 Bruce📍 Maroubra📍 Sydney Sanofi · Tests: Chlamydia mRNA Vaccine, Placebo Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination NCT07604103Phase 31 site📍 Malang University of Brawijaya · Tests: Vaxigrip, antibiotic treatments, percutaneus coronary intervention Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays NCT06607003Phase 11 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: P. vivax challenge agent derived from PvHMB-CCE001 Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) NCT05672927Phase 41 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method NCT07428005n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Delphi Consensus Process TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hema… Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination NCT06380114NA1 site📍 Rochester University of Rochester · Tests: Communication, Standing Orders Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults NCT07838298Phase 41 site📍 Seoul Korea University Guro Hospital · Tests: Standard dose influenza vaccine, MF59 adjuvanted influenza vaccine, High dose influenza vaccine Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE NCT06336317Phase 43 sites📍 Aarhus📍 Örebro📍 Cambridge Region Örebro County · Tests: Influenza vaccine, Placebo Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania NCT04953130Phase 41 site📍 Mwanza London School of Hygiene and Tropical Medicine · Tests: Gardasil® HPV vaccine A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa NCT07379580Phase 26 sites📍 Kinshasa📍 Kinshasa📍 Cape Town BioNTech SE · Tests: BNT166a, Placebo Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions NCT07617376Phase 41 site📍 Wroclaw Wroclaw Medical University · Tests: Influenza vaccination Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility NCT07310472NA1 site📍 Turku Turku University Hospital · Tests: Possibility to get live attenuated nasal influenza vaccine at daycare A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) NCT05334706Phase 41 site📍 L'Hospitalet de Llobregat Miquel Angel Pavon Ribas · Tests: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Bone Marrow and Peripheral Blood Immune Responses Study NCT05616546Phase 41 site📍 Atlanta Emory University · Tests: Influenza Vaccine Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean NCT04839757n/a1 site📍 Fort-de-France University Hospital Center of Martinique Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination NCT06995157NA1 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Offering HPV vaccine Second Dose of Varicella Vaccine in Healthy Children NCT07475000Phase 35 sites📍 Akdeniz📍 Ankara📍 Ankara Sinovac (Dalian) Vaccine Technology Co., Ltd. · Tests: PROVARIX
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy